About Us

Verve Therapeutics was created with a singular focus: to protect the world from cardiovascular disease

Our Mission

We are striving to build the preeminent company developing gene editing medicines to treat patients with cardiovascular disease, leveraging the expertise and capabilities of our team whose singular focus is on addressing the root causes of the world’s most common cause of death. Our goal is to disrupt today’s chronic care model for treating cardiovascular disease by providing a new therapeutic approach with single-course gene editing treatments.

Verve brings together multiple breakthroughs in 21st century biomedicine — human genetic analysis, gene editing, messenger RNA (mRNA) -based therapies and lipid nanoparticle (LNP) delivery  — to realize a new future of longevity and vitality for tens of millions of people around the globe with or at risk for cardiovascular disease.

Verve Team

Verve has been purpose-built for the task ahead, with a team of world-leading experts in cardiovascular medicine, human genetics, gene editing, delivery technologies, drug development and commercialization.

 

Adelman, Burt, M.D.
Burt Adelman, M.D.
Co-Founder and Chairman of the Board
Amaonye, Michael
Michael Amaonye
Research Associate
Ashe, Andrew, J.D.
Andrew Ashe, J.D.
President and Chief Operating Officer
Beach, Aaron
Aaron Beach
Associate Director, Analytical Chemistry
Beaudoin, Maggie
Maggie Beaudoin
Vice President, Finance
Bellinger, Andrew, M.D., Ph.D.
Andrew Bellinger, M.D., Ph.D.
Chief Scientific Officer
Biswas, Souvik, Ph.D.
Souvik Biswas, Ph.D.
Principal Scientist, Formulation & Chemistry
Braun, Maurine
Maurine Braun
Senior Manager, Preclinical Operations and Toxicology
Casaz, Paul
Paul Casaz, Ph.D.
Director, Formulation and Characterization
Chadwick, Alexandra, Ph.D.
Alexandra Chadwick, Ph.D.
Associate Director, Preclinical Research and Development
Chen, Huei-Mei
Huei-Mei Chen, Ph.D.
Senior Scientist, Gene Editing
Cheng, Christopher J., Ph.D.
Christopher J. Cheng, Ph.D.
Senior Director, RNA Technology and Manufacturing
Clendaniel, Victoria
Victoria Clendaniel
Senior Research Associate
Cook, Angela
Angela Cook
Chief of Staff
Davis, Kristopher
Kristopher Davis
Facilities and Lab Assistant
Dembla, Ishwin
Ishwin Dembla, M.S.
Senior Scientist, Analytical Chemistry
DeNizio, Jamie, Ph.D.
Jamie DeNizio, Ph.D.
Senior Scientist
DePeter, Joseph
Joseph DePeter
Senior Process Development Engineer, mRNA Process Development and Tech Transfer
Dorsey, Andrew
Andrew Dorsey
Research Associate, Formulation
Dutta, Chaitali, Ph.D.
Chaitali Dutta, Ph.D.
Principal Scientist, Pharmacology and Toxicology
Eisner, Robin
Robin Eisner
Administrative and Operations Manager
El-Gamal, Yasser
Yasser (Yas) El-Gamal
Vice President, Legal Affairs and Chief Intellectual Property Counsel
Falzone, Richard
Richard Falzone
Vice President, Clinical Operations
Franaszek, Nicole
Nicole Franaszek
Research Associate, Formulation
Fuselli, Nancy
Nancy Fuselli, BSc, RAC
Director, Quality Affairs
Ganey, Jack
Jack Ganey
Associate Scientist
Gangopadhyay, Soumya
Soumya Gangopadhyay, Ph.D.
Senior Scientist, Bioassays and Editing
Garcia, Sara, Ph.D.
Sara Garcia, Ph.D.
Senior Scientist, Computational Biology
Garrity, Ryan
Ryan Garrity
Senior In Vivo/In Vitro Research Associate
Gichuru, Kevin
Kevin Gichuru
Accounting Manager
Glass, Zachary
Zachary Glass, Ph.D.
Scientist, Formulation
Greenfield, Matthew
Matthew Greenfield
Associate Director, Laboratory Operations
Iyer, Sowmya
Sowmya Iyer, Ph.D.
Senior Scientist, Computational Biology
James, Paris
Paris James
Research Associate, RNA Technology
Jayaram, Hari
Hari Jayaram, Ph.D.
Vice President, Editing and Discovery
Joung, J. Keith, M.D., Ph.D.
J. Keith Joung, M.D., Ph.D.
Co-Founder
Kasiewicz, Lisa, Ph.D.
Lisa Kasiewicz, Ph.D.
Senior Scientist, Formulations
Kathiresan, Sekar, M.D.
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
Kirk, Jaime
Jaime Kirk
Senior Manager, Technical Accounting
Klausman, Danielle
Danielle Klausman
Senior Manager, Regulatory CMC
Kumar, Sunita
Sunita Kumar
Associate Director, Quality Assurance
Kwon, Jeong-Ah
Jeong-Ah Kwon
Scientist, RNA Analytics
Lavoie, Jennifer
Jennifer Lavoie
Associate Director, CMC Program Management
Li, Jeff
Jeff Li
Associate Scientist
Li, Jimmy
Jimmy Li
Staff Accountant
Madsen, James
James Madsen, Ph.D.
Associate Director, Mass Spectrometry
Malyala, Padma
Padma Malyala
Executive Director, Formulation and Characterization
Mangano, Jessica
Jessica Mangano
Senior Engineer, RNA Technology and Manufacturing
Matsumoto, Yuri
Yuri Matsumoto, Ph.D.
Principal Scientist, Bioanalytical and Translational Sciences
Mazzola, Anne Marie
Anne Marie Mazzola
Study Coordinator and Scientist, Pharmacology and Toxicology
Minaya, Harlisa
Harlisa Minaya
Senior Human Resources Generalist
Mizoguchi, Taiji, Ph.D.
Taiji Mizoguchi, Ph.D.
Senior Scientist, In Vivo Biology
Musunuru, Kiran, M.D., Ph.D., MPH
Kiran Musunuru, M.D., Ph.D., MPH
Co-Founder and Senior Scientific Advisor
Nagpal, Ash
Ash Nagpal
Senior Process Engineer
Naigles, Robyn
Robyn Naigles
Administrative and Operations Associate
Nasrullah, Yusuf
Yusuf Nasrullah
Scientist
Nickerson, Joan
Joan Nickerson
Senior Vice President, Human Resources and Facilities
O’Neil, April
April O'Neil
Associate Director, Human Resources
Pacheco, Alline
Alline Pacheco, Ph.D.
Senior Scientist, Gene Editing
Philippakis, Anthony, M.D., Ph.D.
Anthony Philippakis, M.D., Ph.D.
Co-Founder and Scientific Advisory Board Member
Platt, Colin
Colin Platt, Ph.D.
Scientist, In Vivo Pharmacology
Politi, Jason
Jason Politi
Senior Vice President, Technical Operations
Powell, Brent V.
Brent V. Powell, Ph.D.
Scientist
Rajeev, Kallanthottathil G., Ph.D.
Kallanthottathil G. Rajeev, Ph.D.
Vice President, CMC
Reiss, Caroline, Ph.D.
Caroline Reiss, Ph.D.
Senior Scientist, RNA Technology and Manufacturing
Ren, Huilan
Huilan Ren
Associate Scientist
Rohde, Ellen, Ph.D.
Ellen Rohde, Ph.D.
Vice President, Pharmacology and Toxicology
Rozen, Issi, MBA
Issi Rozen, MBA
Co-Founder and Strategic Advisor
Sanjeev, Athul
Athul Sanjeev
Research Associate
Shatzer, Wynn
Wynn Shatzer
Research Associate
Shay, Jax
Jax Shay
Research Associate, Formulation and Characterization
Sheely, Andrew
Andrew Sheely
Executive Director, Information Technology
Stahley, Mary
Mary Stahley, Ph.D.
Associate Director, Process Development
Stevens, Casey
Casey Stevens, Ph.D.
Scientist, RNA Process Development
Stolz, Leslie, Ph.D.
Leslie Stolz, Ph.D.
Vice President, Regulatory Affairs
Street, Lynnsey
Lynnsey Street
Associate Scientist
Ticho, Barry, M.D., Ph.D.
Barry Ticho, M.D., Ph.D.
Co-Founder
Vafai, Scott
Scott Vafai, M.D.
Executive Director, Translational Medicine
Wang, Kui, Ph.D.
Kui Wang, Ph.D.
Senior Scientist
Wong, Francis
Francis Wong
Associate Scientist

Board of Directors

Adelman, Burt, M.D.
Burt Adelman, M.D.
Co-Founder and Chairman of the Board
Casdin, Eli
Eli Casdin, MBA
Board Observer
Evans, John, MBA
John Evans, MBA
Board Member
Kathiresan, Sekar, M.D.
Sekar Kathiresan, M.D.
Co-Founder, Chief Executive Officer and Board Member
MacLean, Michael
Michael MacLean
Board Member
Mikhail, Sheila
Sheila Mikhail, J.D., MBA
Board Member
Nikolic, Boris, M.D.
Boris Nikolic, M.D.
Board Observer
Yeshwant, Krishna, M.D., MBA
Krishna Yeshwant, M.D., MBA
Board Member

Scientific Advisory Board

Braunwald, Eugene
Eugene Braunwald, M.D.
Scientific Advisory Board Member
Geall, Andrew
Andrew Geall, Ph.D.
Scientific Advisory Board Member
Heaton, Penny
Penny M. Heaton, M.D.
Scientific Advisory Board Member
Philippakis, Anthony, M.D., Ph.D.
Anthony Philippakis, M.D., Ph.D.
Co-Founder and Scientific Advisory Board Member
Rader, Daniel
Daniel J. Rader, M.D.
Scientific Advisory Board Member

Collaborations and Licensing

Verve has assembled a portfolio of gene editing and delivery technologies through strategic collaborations and licensing agreements with industry leaders, including Beam Therapeutics, the Broad Institute, Harvard University and Acuitas Therapeutics, Inc.

Investors

Verve is supported by a top-tier syndicate of investors who share our vision for tackling the world’s most urgent health challenge.